CBMG
Cellular Biomedicine Group, Inc.
CBMG
CBMG
Delisted
CBMG was delisted on the 19th of February, 2021.
40 hedge funds and large institutions have $59.4M invested in Cellular Biomedicine Group, Inc. in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $5K
Holders
40
Holding in Top 10
–
Calls
–
Puts
$5K
Top Buyers
| 1 | +$11.3M | |
| 2 | +$6.72M | |
| 3 | +$6.62M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$4.94M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$865K |
Top Sellers
| 1 | -$286K | |
| 2 | -$205K | |
| 3 | -$136K | |
| 4 |
MIM
MetLife Investment Management
Whippany,
New Jersey
|
-$110K |
| 5 |
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
|
-$80.8K |